作者: Lisa G. Suter , A. David Paltiel , Benjamin N. Rome , Daniel H. Solomon , Ilya Golovaty
DOI: 10.1056/NEJMP1109285
关键词:
摘要: The FDA approves many devices on the basis of similarity to precursors, possibly encouraging development slightly improved, higher-cost devices. A modeling approach can illuminate interplay among efficacy and durability, patient characteristics, costs, outcomes.